Welcome to
RBP World!
Drugs target to PSMA2
| Drug name | Drug type | Disease/phenotype | Mechanism of action(MoA) | Phase | Status | Source |
|---|---|---|---|---|---|---|
| MARIZOMIB | Small molecule | ependymoma | 20S proteosome inhibitor | 2.0 | Terminated | ClinicalTrials |
| OPROZOMIB | Small molecule | hepatocellular carcinoma | 26S proteosome inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| MARIZOMIB | Small molecule | anaplastic ependymoma | 20S proteosome inhibitor | 2.0 | Terminated | ClinicalTrials |
| OPROZOMIB | Small molecule | Waldenstrom macroglobulinemia | 26S proteosome inhibitor | 1.0 | Terminated | ClinicalTrials |
| MARIZOMIB | Small molecule | multiple myeloma | 20S proteosome inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| MARIZOMIB | Small molecule | lymphoma | 20S proteosome inhibitor | 1.0 | Completed | ClinicalTrials |
| OPROZOMIB | Small molecule | cancer | 26S proteosome inhibitor | 1.0 | Terminated | ClinicalTrials |
| MARIZOMIB | Small molecule | cancer | 20S proteosome inhibitor | 1.0 | Completed | ClinicalTrials |
| OPROZOMIB | Small molecule | multiple myeloma | 26S proteosome inhibitor | 1.0 | Terminated | ClinicalTrials |
| MARIZOMIB | Small molecule | multiple myeloma | 20S proteosome inhibitor | 1.0 | Completed | ClinicalTrials |
| OPROZOMIB | Small molecule | neoplasm | 26S proteosome inhibitor | 1.0 | Completed | ClinicalTrials |
| OPROZOMIB | Small molecule | multiple myeloma | 26S proteosome inhibitor | 1.0 | Completed | ClinicalTrials |
| MARIZOMIB | Small molecule | glioblastoma multiforme | 20S proteosome inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| MARIZOMIB | Small molecule | glioblastoma multiforme | 20S proteosome inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |